According to Bristol-Myers Squibb's latest financial reports and stock price the company's current number of shares outstanding is 2,057,000,000. At the end of 2023 the company had 2,057,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 2.05 B | -2.42% |
2022 | 2.10 B | -2.09% |
2021 | 2.15 B | -4.4% |
2020 | 2.25 B | 17.41% |
2019 | 1.91 B | 17.52% |
2018 | 1.63 B | -0.24% |
2017 | 1.63 B | -2.15% |
2016 | 1.67 B | 0.18% |
2015 | 1.66 B | 0.54% |
2014 | 1.66 B | 0.73% |
2013 | 1.64 B | 0.24% |
2012 | 1.64 B | -2.78% |
2011 | 1.69 B | -0.94% |
2010 | 1.70 B | -12.86% |
2009 | 1.95 B | -1.06% |
2008 | 1.98 B | 0.2% |
2007 | 1.97 B | 0.66% |
2006 | 1.96 B | 0.41% |
2005 | 1.95 B | 0.51% |
2004 | 1.94 B | 0.26% |
2003 | 1.94 B | -11.04% |
2002 | 2.18 B | 12.59% |
2001 | 1.93 B |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 2,407,178,000 | 17.02% | ๐บ๐ธ USA |
![]() Novartis NVS | 2,062,000,000 | 0.24% | ๐จ๐ญ Switzerland |
![]() Pfizer PFE | 5,646,000,000 | 174.48% | ๐บ๐ธ USA |
![]() AbbVie ABBV | 1,767,000,000 | -14.10% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | 949,303,000 | -53.85% | ๐บ๐ธ USA |
![]() Amgen AMGN | 535,000,000 | -73.99% | ๐บ๐ธ USA |
![]() Sanofi SNY | 2,506,400,000 | 21.85% | ๐ซ๐ท France |
![]() Biogen BIIB | 144,800,000 | -92.96% | ๐บ๐ธ USA |
![]() Merck MRK | 2,535,293,793 | 23.25% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | 3,098,000,000 | 50.61% | ๐ฌ๐ง UK |